Table 1 Characteristics of the study population at inclusion in the WADANUT study, 2014-2016, N=326
Inclusion characteristics | Total N=326 | Benin N=91 | Côte d’Ivoire N=158 | Togo N=77 | p-value* | ||||
|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | ||
Socio-demographic data | |||||||||
Age at inclusion | 0.415 | ||||||||
0-2yrs | 27 | 8.3 | 11 | 12.1 | 13 | 8.2 | 3 | 3.9 | |
2-5yrs | 84 | 25.8 | 24 | 26.4 | 39 | 24.7 | 21 | 27.3 | |
5-10yrs | 215 | 66.0 | 56 | 61.5 | 106 | 67.1 | 53 | 68.8 | |
Sex | 0.593 | ||||||||
Males | 170 | 52.1 | 46 | 50.5 | 87 | 55.1 | 38 | 49.4 | |
Females | 156 | 47.9 | 45 | 49.5 | 71 | 44.9 | 39 | 50.6 | |
Primary caregiver | 0.001 | ||||||||
Father, mother | 269 | 82.5 | 79 | 86.8 | 118 | 74.7 | 72 | 93.5 | |
Other family member | 47 | 14.4 | 12 | 13.2 | 31 | 19.6 | 4 | 5.2 | |
Other (institute or missing) | 10 | 3.1 | 0 | 0.0 | 9 | 5.7 | 1 | 1.3 | |
Orphanhood | 0.570 | ||||||||
Non orphan | 236 | 72.4 | 66 | 72.5 | 111 | 70.3 | 59 | 76.6 | |
One parent | 84 | 25.8 | 22 | 24.2 | 44 | 27.8 | 18 | 23.4 | |
Two parents | 6 | 1.8 | 3 | 3.3 | 3 | 1.9 | 0 | 0.0 | |
Treatments | |||||||||
On antiretroviral therapy | 298 | 91.4 | 79 | 86.8 | 142 | 89.9 | 77 | 100.0 | 0.001 |
Based on PIs | 61 | 20.5 | 18 | 22.8 | 26 | 18.3 | 17 | 22.1 | 0.294 |
Based on NRTIs | 228 | 76.5 | 61 | 77.2 | 111 | 78.2 | 56 | 72.7 | |
Missing data | 9 | 3.0 | 0 | 0.0 | 5 | 3.5 | 4 | 5.2 | |
Duration on ART | 0.018 | ||||||||
0-2 yrs | 120 | 40.3 | 37 | 40.7 | 65 | 45.8 | 18 | 23.4 | |
2-5 yrs | 105 | 35.2 | 25 | 27.5 | 44 | 31.0 | 36 | 46.8 | |
5-10yrs | 71 | 23.8 | 17 | 18.7 | 33 | 23.2 | 21 | 27.3 | |
Missing data | 2 | 0.7 | 0 | 0.0 | 0 | 0.0 | 2 | 2.6 | |
On Cotrimoxazole prophylaxis | 242 | 74.2 | 72 | 79.1 | 146 | 92.4 | 77 | 100.0 | <0.001 |
Clinical status and co-morbidities | |||||||||
Immunodeficiency for agea | |||||||||
No | 176 | 54.0 | 36 | 39.6 | 97 | 61.4 | 43 | 55.8 | <0.001 |
Moderate | 39 | 12.0 | 6 | 6.6 | 25 | 15.8 | 8 | 10.4 | |
Severe | 55 | 16.9 | 16 | 17.6 | 33 | 20.9 | 6 | 7.8 | |
Missing data | 56 | 17.2 | 33 | 36.3 | 3 | 1.9 | 20 | 26.0 | |
WHO stage | |||||||||
I-II | 214 | 65.6 | 79 | 86.8 | 61 | 38.6 | 74 | 96.1 | <0.001 |
III-IV | 86 | 26.4 | 11 | 12.1 | 73 | 46.2 | 2 | 2.6 | |
Missing data | 26 | 8.0 | 1 | 1.1 | 24 | 15.2 | 1 | 1.3 | |
Viral load | <0.001 | ||||||||
<500 | 52 | 16.0 | 37 | 40.7 | 16 | 10.1 | 0 | 0.0 | |
>500 | 78 | 23.9 | 36 | 39.6 | 41 | 25.9 | 0 | 0.0 | |
Missing data | 196 | 60.1 | 18 | 19.8 | 101 | 63.9 | 77 | 100.0 | |
Opportunistic infections during the last 6 months | |||||||||
Tuberculosis | 8 | 2.5 | 2 | 2.2 | 6 | 3.8 | 0 | 0.0 | 0.262 |
Pneumonia | 23 | 7.1 | 10 | 11.0 | 8 | 5.1 | 5 | 6.5 | 0.208 |
Malaria | 47 | 14.4 | 6 | 6.6 | 9 | 5.7 | 32 | 41.6 | <0.001 |
Diarrhoea | 17 | 5.2 | 4 | 4.4 | 9 | 5.7 | 4 | 5.2 | 0.948 |
Other (?) | 17 | 5.2 | 4 | 4.4 | 15 | 9.5 | 34 | 44.2 | <0.001 |
Malnutritionb | |||||||||
Underweight (Weight-for-age) | 0.128 | ||||||||
No | 245 | 75.2 | 65 | 71.4 | 115 | 72.8 | 65 | 84.4 | |
Moderate | 55 | 16.9 | 15 | 16.5 | 30 | 19.0 | 10 | 13.0 | |
Severe | 26 | 8.0 | 11 | 12.1 | 13 | 8.2 | 2 | 2.6 | |
Wasting (Weight-for-Height, BMI for age) | 0.170 | ||||||||
No | 292 | 89.6 | 82 | 90.1 | 135 | 85.4 | 75 | 97.4 | |
Moderate | 25 | 7.7 | 7 | 7.7 | 17 | 10.8 | 1 | 1.3 | |
Severe | 9 | 2.8 | 2 | 2.2 | 6 | 3.8 | 1 | 1.3 | |
Stunting (Height-for-age) | 0.376 | ||||||||
No | 232 | 71.2 | 62 | 68.1 | 118 | 74.7 | 52 | 67.5 | |
Moderate | 62 | 19.0 | 16 | 17.6 | 28 | 17.7 | 18 | 23.4 | |
Severe | 32 | 9.8 | 13 | 14.3 | 12 | 7.6 | 7 | 9.1 | |